Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Antibiotic Dependent Pouchitis
NCT02782325Phase 2Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Fecal Microbiota Transplantation Capsule in pouchitis (2 arms), sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Number of Patients With FMT Related Adverse Event at 24 weeks. Started Jun 2017; status: terminated.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT02782325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782325.